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Supplementary Fig S1. Characteristics of induced hepatocytes. A Heatmap showing the 
gene expression changes measured by RNA-seq during the conversion of human fibroblasts to 
induced hepatocytes (iHeps) at early time-point (5 days post-transduction) and at 4 weeks of 
iHep differentiation with hepatocyte marker genes and Notch signaling pathway genes 
highlighted in red. Log2(transcripts per million, TPM) values for collated triplicates are shown. 
B Heatmap showing log2(fold change, FC) values from RNA-seq analysis for two primary 
human hepatocytes, Lon_Hep (Lonza) and SC_Hep (ScienCell), and iHeps at 4 weeks of 
transdifferentiation against control fibroblasts (mean, n=3). Genes differentially expressed in 
both primary hepatocyte samples against control fibroblasts are shown for all conditions (see 
Materials and methods for details). C Oil-Red-O staining showing lipid accumulation and 
Periodic Acid-Schiff (PAS) staining showing glycogen storage for iHeps at 6 weeks post-























































Supplementary Fig. S2. Comparison of oncogene-transduced iHeps to primary 
hepatocytes. Heatmap showing log2(fold change, FC) values from RNA-seq analysis against 
control fibroblasts for two primary human hepatocytes, Lon_Hep (Lonza) and SC_Hep 
(ScienCell), iHeps at 4 weeks of transdifferentiation, and iHeps transduced with CMT+sgTP53 
(mean, n=3), as well as for iHeps transduced with combinations of two oncogenes (CT, 
CTNNB1+TERT; MT, MYC+TERT; CM, CTNNB1+MYC; mean, n=2) two weeks after 















































































Supplementary Fig S3. Marker genes from scRNA-seq analysis. Clustered heatmap 
showing the expression levels of cluster-specific marker genes (the expression of a gene in a 
particular cell relative to the average expression of that gene across all cells), with Bonferroni 
corrected p-value < 0.01 and average log2 fold change > 0.2 or < -0.2, from single cell RNA-
seq analysis. Color code illustrating sample and cluster identities correspond to the colors in 
Fig 4A and B.  
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Supplementary Fig S4. Gene expression dynamics during iHep differentiation and 
transformation. A Distribution of different scRNA-seq samples along the pseudotime. B 
Heatmap showing the expression dynamics for senescence marker genes [from Marthandan, et 
al., (2016) as cited in the main text] along the pseudotime of iHep differentiation and 
transformation in the scRNA-seq data from control fibroblasts, iHeps at one–three weeks after 
iHep induction, and CMT-iHeps two weeks after oncogenes (the expression of a gene in a 
particular cell relative to the average expression of that gene across all cells is shown). Color 
codes illustrating sample identities correspond to the colors in Fig. 4A.
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Supplementary Fig S5. Correlation of gene expression signature of transformed iHeps to 
cancer types other than liver cancer. Gene set enrichment analysis for transformed iHep-
CMT+sgTP53 cells at p20 compared to control fibroblasts against cancer signatures from 
molecular signatures database (MSigDB). 
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Supplementary Fig S6. Liver cancer signatures analyzed in transformed iHeps. A 
Expression of the leading-edge subsets of genes from gene set enrichment analysis against 
Subclass 2 liver cancer signature [from Hoshida et al., (2009) as cited in the main text] in CMT-
iHeps and CMT+sgTP53-iHeps compared to control fibroblasts (scale bar showing mean 
expression values). B Gene set enrichment analysis (GSEA) results for liver cancer survival 
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Supplementary Fig S7. Hepatocellular carcinoma (HCC) and hepatoblastoma (HB) 
signatures analyzed in transformed iHeps. Gene set enrichment analysis of differentially 
expressed genes analyzed from RNA-seq data in transformed iHep-CMT+sgTP53 cells at p20 
(~22 weeks after oncogene transduction; top) and xenograft tumor generated from them 
(bottom) vs. iHep control against HCC- and HB-signatures generated from previously 
published gene expression data sets for human HCC and HB tumors compared to normal liver 
(see Materials and methods for details). Note the positive normalized enrichment score (NES) 
significantly associated to HCC_UP signature but not to HB_UP signature, and negative NES 




Supplementary Fig S8. Expression of TFs and marker genes during transdifferentiation 
and transformation. Gene expression levels measured by RNA-seq from human liver cancer 
cells lines (HepG2 and HuH7) and during the conversion of human fibroblasts to induced 
hepatocytes (at four weeks of differentiation) and to highly proliferative tumorigenic cells 
(CMT+sgTP53 cells shown at two and 22 weeks after oncogene transduction, as well as RNA 
extracted from the CMT+sgTP53 tumor). Mean from three biological replicates with standard 
deviation for log2[transcripts per million (TPM)] is shown (total expression values combined 



























































Supplementary Fig S9. Induced neurons reprogrammed from human fibroblasts using 
defined TFs. Fluorescent microscope images (40x) of induced neurons with and without 
transduction of medulloblastoma-specific oncogenes (at three weeks of neuronal 
differentiation) visualized using EGFP at ten weeks after neuronal conversion.  
Control iN iN + oncogenes
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Supplementary Table S1. Genomic insertions of lentiviral constructs. Number and 
genomic loci for insertions of lentiviral expression constructs that were used for ectopic 
expression of lineage-specific TFs and oncogenes, detected in the sequencing reads from the 
NaNoMe-seq data from CMT+sgTP53 cells at p20, 22 weeks after oncogene transduction. 
A. Total number of insertions for each detected construct 







B. Genomic coordinates for the insertions supported by more than one Nanopore read 
Insertion locus Lentiviral expression construct Unique reads 
ChrX 138839044 138839050 TERT 8 
Chr1 27684639 27684641 Cas9 10 
Chr1 43317914 43317916 TERT 18 
Chr1 150921674 150921676 Cas9 9 
Chr1 151770393 151770399 MYC 16 
Chr1 226341541 226341544 TERT 12 
Chr4 2867705 2867709 Cas9 9 
Chr6 31611488 31611491 MYC 22 
Chr6 32925912 32925917 TERT 17 
Chr6 33227277 33227279 MYC 11 
Chr6 74230721 74230727 Cas9 23 
Chr6 109580023 109580027 HNF1A 21 
Chr8 6384753 6384754 MYC 14 
Chr9 32980138 32980141 MYC 17 
Chr9 33904383 33904384 TERT 14 
Chr9 130408513 130408518 MYC 9 
Chr9 139308028 139308032 MYC 23 
Chr10 17121499 17121510 Cas9 7 
Chr12 7041910 7041912 MYC 19 
Chr12 56691765 56691769 MYC 10 
Chr15 43116574 43116580 Cas9 6 
Chr16 360600 360606 TERT 4 
Chr16 1887275 1887282 MYC 9 
Chr17 27116562 27116564 MYC 20 
Chr17 31064738 31064743 Cas9 8 
Chr17 38564351 38564353 TERT 11 
Chr17 57883662 57883668 Cas9 9 
Chr19 46123309 46123313 MYC 10 
Chr22 51029725 51029726 TERT 14 
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Supplementary Table S2. Examples of model systems for studying cell fate and 
tumorigenesis. See full citations in the list of references for the main text. 
Model system Reference Approach Key features 
Mogrify Rackham et al., 
(2016) 
A predictive computational 
framework for identifying 
factors for direct cell fate 
conversion 
A systematic approach that aids 
in the development of 
transdifferentiation protocols, 
experimental validation still 
needed for each case 
Human cancer-
derived organoids 
Broutier et al., 
(2017) 
Primary liver cancer-derived 
organoid cultures that 
recapitulate features of 
different liver cancer types 
Enables drug testing and 
molecular analyses in a patient-
specific manner, but each 




human primary cells  
Park et al., 
(2018) 
Oncogenic drivers introduced 
to normal prostate and lung 
epithelial cells generated small 
cell prostate cancer and small 
cell lung cancer cells 
Enables studying defined 
oncogenic factors but limited 
by the availability of suitable 
primary cells and generation of 
neuroendocrine tumors instead 





Chen et al., 
(2019) 
Generation of pulmonary 
neuroendocrine cells and 
small cell lung cancer-like 
tumors from human 
embryonic stem cells (ESC) 
Dynamic approach for studying 
oncogenic factors, but 
intermediate stage in the assay 
is already tumorigenic in mice 




using defined factors 
This manuscript Lineage-specific TFs are used 
for cell fate conversion and 
cancer-specific oncogenes for 
cellular transformation to 
generate liver cancer cells 
Dynamic molecular model that 
enables studying the 
contribution of each factor of 
interest in a systematic manner 
and recapitulating early stages 
of tumorigenesis 
 
Of note, using this model, the 
role of defined tissue-specific 
transcription factors identified 
through Mogrify can be 
investigated together with the 
major human oncogenic drivers 
identified by cancer genetic 
studies, offering a novel 
platform for studying lineage-
specificity of human cancers 




Supplementary Table S3. Sequences of the primers used for qRT-PCR.  











Supplementary Table S4. Codon-optimized sequences used for lentiviral expression of 
HNF4A, TERT, and CTNNB1 T41A 
Gene 
name Coding sequence (5’ → 3’) 
 
HNF4A 
 
ATGAGACTGAGCAAGACCCTGGTGGACATGGATATGGCCGACTACTCCGCAGCACTGGACCCCGCTTATACTACT
CTGGAATTTGAGAACGTGCAGGTCCTGACCATGGGGAATGATACATCCCCATCTGAGGGAACAAACCTGAATGCA
CCAAACTCCCTGGGCGTGTCTGCCCTGTGCGCTATCTGTGGGGATCGGGCAACTGGGAAGCACTACGGAGCCAGC
TCCTGCGACGGGTGTAAGGGATTCTTTCGGAGATCTGTGAGAAAAAACCATATGTACAGTTGCAGGTTCTCACGC
CAGTGCGTGGTCGACAAGGATAAACGCAATCAGTGCCGATATTGTCGGCTGAAGAAATGCTTTCGAGCCGGCATG
AAGAAAGAGGCTGTGCAGAATGAACGAGATCGGATTTCCACCAGGCGCTCTAGTTATGAAGACTCAAGCCTGCCT
TCAATTAACGCACTGCTGCAGGCTGAGGTGCTGAGCCGGCAGATCACATCTCCAGTCAGTGGCATTAATGGGGAT
ATCAGAGCCAAGAAAATCGCATCTATTGCCGACGTGTGCGAGAGTATGAAGGAACAGCTGCTGGTGCTGGTCGAA
TGGGCTAAATACATCCCTGCATTCTGTGAGCTGCCACTGGACGATCAGGTGGCTCTGCTGAGGGCACACGCCGGA
GAGCATCTGCTGCTGGGCGCAACCAAGCGCAGCATGGTGTTTAAAGATGTCCTGCTGCTGGGCAACGACTATATT
GTGCCTAGGCACTGTCCAGAGCTGGCCGAAATGTCAAGAGTGAGCATCAGGATTCTGGATGAGCTGGTCCTGCCA
TTCCAGGAACTGCAGATCGACGATAATGAGTACGCATATCTGAAGGCCATCATTTTCTTTGACCCCGATGCTAAA
GGCCTGAGCGACCCTGGCAAGATCAAGCGGCTGAGGAGCCAGGTGCAGGTCTCCCTGGAAGACTACATCAACGAT
CGCCAGTATGACTCCCGCGGACGATTTGGCGAGCTGCTGCTGCTGCTGCCTACTCTGCAGTCTATTACCTGGCAG
ATGATCGAACAGATTCAGTTCATCAAGCTGTTTGGCATGGCCAAAATCGATAATCTGCTGCAGGAGATGCTGCTG
GGAGGAAGTCCATCAGACGCTCCTCACGCACACCATCCACTGCACCCCCATCTGATGCAGGAGCATATGGGGACT
AACGTGATCGTCGCTAATACTATGCCCACCCACCTGAGTAACGGGCAGATGTGCGAATGGCCACGACCAAGAGGA
CAGGCAGCTACACCTGAGACTCCTCAGCCATCCCCACCTGGAGGAAGCGGATCCGAACCATACAAGCTGCTGCCC
GGCGCTGTGGCAACAATTGTCAAACCCCTGTCCGCCATTCCCCAGCCTACCATCACAAAGCAGGAAGTGATCTAG 
 
TERT 
 
ATGCCAAGAGCACCAAGATGCCGAGCCGTGAGAAGTCTGCTGAGATCCCATTATAGAGAGGTCCTGCCCCTGGCT
ACATTCGTGAGACGCCTGGGCCCACAGGGGTGGCGACTGGTCCAGCGAGGGGACCCAGCAGCTTTTCGGGCACTG
GTGGCACAGTGCCTGGTGTGCGTGCCATGGGATGCACGACCACCTCCAGCAGCACCTAGTTTCAGACAGGTGTCA
TGCCTGAAAGAACTGGTCGCACGGGTGCTGCAGCGGCTGTGCGAGAGGGGAGCCAAGAACGTGCTGGCCTTCGGA
TTTGCTCTGCTGGACGGAGCAAGGGGAGGACCACCTGAGGCCTTTACCACAAGTGTCCGCTCATACCTGCCAAAT
ACCGTGACAGATGCACTGCGAGGATCCGGAGCATGGGGACTGCTGCTGCGAAGAGTGGGAGACGATGTGCTGGTC
CACCTGCTGGCTAGATGCGCACTGTTCGTGCTGGTCGCACCCTCTTGCGCATACCAGGTGTGCGGACCACCACTG
TATCAGCTGGGAGCTGCAACCCAGGCTAGGCCTCCACCACACGCAAGCGGACCAAGGCGCCGACTGGGATGTGAA
CGGGCTTGGAACCATTCCGTCAGAGAGGCAGGAGTGCCTCTGGGACTGCCAGCACCTGGGGCTCGGAGAAGGGGA
GGCAGTGCCTCAAGGAGCCTGCCACTGCCAAAGCGACCACGACGAGGAGCAGCTCCTGAACCAGAGAGAACTCCA
GTGGGACAGGGCAGCTGGGCACACCCAGGAAGGACCCGAGGACCTTCAGACAGGGGATTCTGCGTGGTCAGCCCT
GCACGACCAGCAGAGGAAGCTACAAGCCTGGAGGGGGCTCTGTCCGGAACTCGACACAGCCATCCATCCGTGGGC
CGCCAGCACCATGCAGGACCTCCATCCACCTCTCGACCACCTCGGCCTTGGGACACACCATGTCCACCCGTGTAC
GCCGAAACTAAACACTTTCTGTATAGCTCCGGAGATAAGGAGCAGCTGCGGCCAAGTTTCCTGCTGTCTAGTCTG
AGACCCTCACTGACTGGCGCCCGGAGACTGGTGGAAACCATCTTTCTGGGAAGCAGACCCTGGATGCCTGGAACA
CCAAGGCGCCTGCCACGACTGCCTCAGCGATACTGGCAGATGAGGCCCCTGTTCCTGGAGCTGCTGGGGAATCAC
GCCCAGTGCCCTTATGGAGTGCTGCTGAAAACCCATTGTCCCCTGAGAGCAGCAGTCACACCTGCTGCAGGCGTG
TGCGCAAGGGAAAAGCCACAGGGAAGCGTGGCAGCTCCAGAGGAAGAGGACACCGATCCTCGACGGCTGGTGCAG
CTGCTGCGACAGCACTCAAGCCCCTGGCAGGTCTACGGATTCGTGCGGGCCTGTCTGAGAAGGCTGGTGCCTCCA
GGACTGTGGGGAAGCCGGCACAACGAACGCCGATTTCTGAGAAACACTAAGAAATTCATCTCCCTGGGCAAGCAT
GCTAAACTGTCTCTGCAGGAGCTGACCTGGAAGATGTCCGTGAGGGACTGCGCATGGCTGCGGAGATCTCCAGGA
GTCGGATGCGTGCCAGCAGCAGAGCACCGACTGCGAGAAGAGATTCTGGCCAAGTTTCTGCATTGGCTGATGAGC
GTGTACGTGGTCGAACTGCTGCGCTCCTTCTTTTATGTGACAGAGACTACCTTCCAGAAAAACAGACTGTTCTTT
TATAGGAAGAGCGTGTGGAGTAAACTGCAGTCTATCGGCATTCGGCAGCACCTGAAGCGGGTCCAGCTGAGAGAA
CTGAGTGAAGCCGAGGTGAGACAGCATAGGGAGGCACGACCTGCCCTGCTGACCAGCAGACTGAGGTTCATCCCC
AAGCCTGACGGACTGCGCCCAATTGTGAACATGGATTACGTGGTCGGAGCACGGACCTTCCGGCGAGAAAAACGA
GCTGAGCGGCTGACTTCTAGAGTCAAGGCACTGTTCAGTGTGCTGAATTATGAGAGGGCACGACGGCCCGGACTG
CTGGGAGCTTCCGTGCTGGGCCTGGACGATATCCACAGAGCCTGGAGGACCTTTGTCCTGCGCGTGCGAGCTCAG
GACCCACCTCCAGAACTGTACTTCGTGAAGGTCGATGTGACTGGGGCATATGACACCATCCCACAGGATAGACTG
ACCGAAGTGATCGCCTCTATCATCAAGCCCCAGAATACATACTGCGTGAGAAGGTATGCCGTGGTCCAGAAGGCT
GCACACGGCCATGTCAGGAAGGCTTTTAAATCACACGTGAGCACTCTGACCGACCTGCAGCCTTACATGAGACAG
TTCGTGGCTCATCTGCAGGAGACATCCCCACTGAGGGACGCAGTGGTCATCGAACAGTCCTCTAGTCTGAACGAG
GCTTCAAGCGGCCTGTTCGACGTGTTCCTGAGATTCATGTGCCACCATGCAGTCCGGATTAGAGGGAAAAGCTAC
GTGCAGTGTCAGGGCATCCCTCAGGGGTCCATTCTGTCTACCCTGCTGTGCAGCCTGTGCTATGGCGACATGGAA
AATAAGCTGTTTGCTGGGATCCGCCGAGATGGACTGCTGCTGCGCCTGGTCGACGATTTTCTGCTGGTGACACCC
CACCTGACTCATGCCAAAACCTTCCTGAGGACACTGGTCCGCGGAGTGCCAGAGTACGGATGCGTGGTCAACCTG
AGAAAGACAGTGGTCAATTTCCCTGTCGAAGATGAGGCTCTGGGGGGAACTGCATTTGTGCAGATGCCTGCCCAC
GGACTGTTCCCATGGTGTGGCCTGCTGCTGGACACAAGGACTCTGGAGGTGCAGTCTGATTACTCCTCTTATGCC
CGAACCAGTATTCGGGCTTCACTGACCTTCAACCGCGGATTCAAGGCCGGCCGAAATATGCGGAGAAAACTGTTT
GGCGTGCTGCGGCTGAAGTGCCATTCTCTGTTCCTGGACCTGCAGGTCAACAGTCTGCAGACCGTGTGCACAAAT
ATCTACAAAATTCTGCTGCTGCAGGCCTATCGCTTTCACGCTTGCGTCCTGCAGCTGCCTTTCCATCAGCAAGTG
TGGAAGAACCCAACTTTCTTTCTGAGAGTGATCAGCGATACCGCTTCCCTGTGCTACTCTATTCTGAAGGCTAAA
AATGCAGGCATGAGTCTGGGAGCAAAAGGAGCAGCTGGACCACTGCCCTCAGAAGCAGTGCAGTGGCTGTGCCAC
CAGGCCTTTCTGCTGAAGCTGACAAGGCATCGCGTCACTTATGTGCCACTGCTGGGGTCACTGAGGACTGCCCAG
ACCCAGCTGAGCCGCAAACTGCCCGGAACAACTCTGACCGCTCTGGAGGCAGCCGCTAACCCAGCACTGCCCAGC
GACTTCAAGACAATCCTGGATTAG  
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CTNNB1 
 
ATGGCAACACAGGCCGACCTGATGGAACTGGATATGGCAATGGAACCCGACAGAAAGGCAGCCGTCTCACACTGG
CAGCAGCAGAGCTACCTGGATTCCGGGATCCACTCTGGAGCAACCGCCACAGCTCCCTCACTGAGCGGGAAGGGA
AACCCTGAGGAAGAGGACGTCGATACCAGCCAGGTGCTGTACGAATGGGAGCAGGGCTTCTCCCAGTCTTTTACA
CAGGAGCAGGTGGCCGACATCGATGGGCAGTATGCAATGACACGAGCTCAGAGGGTGCGCGCAGCTATGTTCCCC
GAAACTCTGGATGAGGGCATGCAGATTCCTTCCACACAGTTTGACGCAGCCCACCCAACTAATGTGCAGAGGCTG
GCCGAACCCTCTCAGATGCTGAAGCATGCTGTGGTCAACCTGATCAATTATCAGGACGATGCTGAACTGGCAACT
CGCGCCATTCCAGAGCTGACCAAGCTGCTGAACGACGAAGATCAGGTGGTCGTGAACAAGGCTGCAGTGATGGTC
CACCAGCTGAGCAAGAAAGAGGCATCCCGACATGCCATCATGCGGTCTCCCCAGATGGTCAGTGCCATTGTGAGG
ACCATGCAGAACACAAATGATGTGGAGACAGCTCGCTGTACAGCAGGCACTCTGCACAACCTGAGTCACCATAGG
GAAGGGCTGCTGGCAATCTTCAAGTCAGGCGGGATTCCTGCCCTGGTGAAAATGCTGGGCAGTCCAGTGGACTCA
GTCCTGTTTTACGCCATCACCACACTGCACAATCTGCTGCTGCATCAGGAGGGGGCTAAGATGGCAGTGCGCCTG
GCAGGAGGCCTGCAGAAAATGGTCGCCCTGCTGAACAAGACCAATGTGAAATTCCTGGCCATCACTACCGACTGC
CTGCAGATTCTGGCTTATGGCAACCAGGAGTCAAAGCTGATCATTCTGGCAAGCGGAGGACCACAGGCTCTGGTG
AATATCATGCGAACTTACACCTATGAAAAACTGCTGTGGACAACTTCCAGAGTGCTGAAGGTCCTGTCTGTGTGT
AGCTCCAACAAACCTGCCATTGTGGAGGCTGGAGGAATGCAGGCACTGGGACTGCACCTGACAGATCCATCACAG
CGCCTGGTGCAGAACTGCCTGTGGACCCTGCGAAATCTGAGCGACGCCGCTACAAAGCAGGAAGGCATGGAGGGG
CTGCTGGGAACTCTGGTGCAGCTGCTGGGGTCTGACGATATCAATGTCGTGACTTGCGCAGCCGGAATTCTGAGT
AACCTGACCTGTAACAATTACAAGAACAAGATGATGGTCTGCCAAGTGGGAGGCATCGAGGCTCTGGTCCGAACA
GTGCTGCGGGCAGGGGACAGAGAAGATATCACTGAGCCTGCCATTTGTGCTCTGAGACACCTGACCAGTAGGCAT
CAGGAAGCAGAGATGGCCCAGAACGCTGTGCGGCTGCACTATGGCCTGCCAGTCGTGGTCAAGCTGCTGCACCCC
CCTTCTCATTGGCCCCTGATCAAAGCTACCGTGGGGCTGATTAGAAACCTGGCACTGTGCCCTGCAAATCACGCA
CCACTGCGAGAGCAGGGAGCAATCCCACGACTGGTCCAGCTGCTGGTGCGGGCTCATCAGGATACTCAGCGGAGA
ACCTCCATGGGGGGAACTCAGCAGCAGTTCGTCGAGGGCGTGCGGATGGAAGAGATCGTGGAAGGCTGTACCGGG
GCACTGCACATTCTGGCCAGAGACGTCCATAACAGGATCGTGATTCGCGGACTGAATACCATCCCCCTGTTTGTG
CAGCTGCTGTACAGCCCTATCGAGAACATTCAGAGAGTCGCTGCAGGCGTGCTGTGCGAACTGGCCCAGGATAAG
GAAGCCGCTGAGGCTATTGAAGCAGAGGGAGCAACAGCCCCCCTGACTGAACTGCTGCACAGCAGGAATGAGGGC
GTCGCCACATACGCAGCCGCTGTGCTGTTCCGCATGAGCGAGGACAAACCCCAGGATTATAAGAAACGGCTGTCC
GTGGAACTGACCTCTAGTCTGTTTAGAACAGAACCTATGGCTTGGAACGAGACCGCAGACCTGGGACTGGATATC
GGAGCACAGGGAGAGCCACTGGGATACAGACAGGACGATCCCAGTTATAGGTCATTCCACAGCGGAGGATACGGA
CAGGATGCACTGGGCATGGACCCTATGATGGAACATGAGATGGGAGGACACCATCCAGGAGCAGACTATCCTGTG
GATGGGCTGCCAGACCTGGGACATGCTCAGGACCTGATGGATGGCCTGCCACCCGGGGACAGCAATCAGCTGGCC
TGGTTTGACACCGATCTGTAG  
 
